Financial Support

RABBIT is financially supported by a joint grant from all companies that provide biologic DMARDs for therapy of rheumatoid arthritis. The sponsorship is unconditional; therefore, solely the principle investigators and the scientific advisory board are responsible for data acquisition and analysis as well as for publication of results; the drug manufacturers have no influence over this.

AbbVie Deutschland GmbH & Co. KG (formerly Abbott GmbH & Co. KG)

Bristol-Myers Squibb GmbH & Co. KGaA

Celltrion Inc.

HEXAL AG

Lilly Deutschland GmbH

MSD Sharp & Dohme GmbH (formerly Essex Pharma GmbH)

Pfizer Pharma GmbH (formerly Wyeth Pharma GmbH)

Roche Pharma AG

Samsung Bioepis Co., Ltd.

Sanofi-Aventis Deutschland GmbH

Swedish Orphan Biovitrum (formerly Amgen) (up to 2012)

UCB Pharma GmbH